WNK2 and endometrial cancer: GnRH-II antagonists were shown to activate apoptosis in human endometrial cancer cells through GnRH-I-R via activation of stress-induced mitogen-activated protein kinases p38 and c-Jun NH2 terminal kinase, leading to activation of pro-apoptotic protein Bax [59].